AIP
CTXR icon

Ameritas Investment Partners’s Citius Pharmaceuticals CTXR Stock Holding History

Ameritas Investment Partners’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-406
Closed -$9.11K – 3151
2024
Q1 		$9.11K Hold
406
– – ﹤0.01% 2839
2023
Q4 		$7.68K Hold
406
– – ﹤0.01% 2907
2023
Q3 		$6.95K Hold
406
– – ﹤0.01% 2927
2023
Q2 		$12.2K Buy
+406
New +$13.4K ﹤0.01% 2834
2022
Q2 		– Sell
-356
Closed -$16K – 3102
2022
Q1 		$16K Hold
356
– – ﹤0.01% 2644
2021
Q4 		$14K Hold
356
– – ﹤0.01% 2778
2021
Q3 		$18K Hold
356
– – ﹤0.01% 2748
2021
Q2 		$31K Buy
+356
New +$21.4K ﹤0.01% 2479

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's CTXR Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 406 shares — an estimated $9.11K sold.

Ameritas Investment Partners first reported a position in CTXR in Q2 2021 and held it in 8 quarters. The position peaked at $31K in Q2 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 406 Citius Pharmaceuticals shares in Q2 2024, an estimated $9.11K.
  • Ameritas Investment Partners first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Ameritas Investment Partners's Citius Pharmaceuticals position peaked at $31K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.